Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 1,265,909 | 1,368,782 | 138,597 | 203,677 | 1,605,267 |
| Cost of Goods | 260,459 | 196,718 | 64,399 | 64,165 | 192,388 |
| Gross Profit | 1,005,450 | 1,172,064 | 74,198 | 139,513 | 1,412,880 |
| Operating Expenses | 848,491 | 1,161,236 | 1,115,098 | 690,344 | 833,820 |
| Operating Income | 157,418 | 11,546 | -1,040,501 | -550,667 | 579,447 |
| Interest Expense | 7,889 | 8,797 | 7,861 | 5,103 | -8,856 |
| Other Income | 170,626 | 171,758 | 180,596 | 195,535 | 137,729 |
| Pre-tax Income | 320,156 | 174,507 | -867,766 | -360,235 | 726,032 |
| Income Tax | 45,884 | -43,324 | 2,154 | -18,131 | 225,414 |
| Net Income Continuous | 274,272 | 217,831 | -869,920 | -342,104 | 500,617 |
| Net Income | $274,272 | $217,831 | $-869,920 | $-342,104 | $500,617 |
| EPS Basic Total Ops | 1.14 | 0.90 | -3.62 | -1.42 | 2.10 |
| EPS Basic Continuous Ops | 1.14 | 0.90 | -3.62 | -1.42 | 2.10 |
| EPS Diluted Total Ops | 1.15 | 0.89 | -3.62 | -1.42 | 2.08 |
| EPS Diluted Continuous Ops | 1.15 | 0.89 | -3.62 | -1.42 | 2.08 |
| EPS Diluted Before Non-Recurring Items | 1.15 | 0.89 | -3.62 | N/A | N/A |
| EBITDA(a) | $334,077 | $62,370 | $-987,101 | $-509,085 | $664,094 |